Stay updated on Cabozantinib vs Chemotherapy in Eye Melanoma Clinical Trial
Sign up to get notified when there's something new on the Cabozantinib vs Chemotherapy in Eye Melanoma Clinical Trial page.

Latest updates to the Cabozantinib vs Chemotherapy in Eye Melanoma Clinical Trial page
- Check4 days agoChange DetectedThe footer revision changed from v3.7.2 to v3.8.0, while the page continues to show a 403 Forbidden error.SummaryDifference0.2%

- Check11 days agoNo Change Detected
- Check18 days agoChange DetectedA general NIH notice about terminology during a website transition appears at the top of the page, and the site revision advances to v3.7.2. The study record content remains unavailable behind a 403 error.SummaryDifference1%

- Check32 days agoChange DetectedThe ClinicalTrials.gov footer revision label changes from v3.7.0 to v3.7.1; the page continues to show a 403 Forbidden error.SummaryDifference0.2%

- Check46 days agoChange DetectedA 403 Forbidden error now appears, replacing the study record content. The view that previously displayed the trial's drug names and related details has been replaced by an error page.SummaryDifference17%

- Check53 days agoChange DetectedRevision updated from v3.6.6 to v3.7.0, indicating a minor platform update behind the scenes. This change does not modify the study details, eligibility criteria, or results text visible to users.SummaryDifference0.0%

- Check67 days agoChange DetectedThe page's revision tag was updated to v3.6.6, replacing the previous v3.6.5 to reflect a minor maintenance update.SummaryDifference0.0%

Stay in the know with updates to Cabozantinib vs Chemotherapy in Eye Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Cabozantinib vs Chemotherapy in Eye Melanoma Clinical Trial page.